There are a number of misconceptions about the use of biologic medications for atopic dermatitis. Find out what experts say ...

Incyte's cream for the treatment of moderate atopic dermatitis in adults has been recommended for approval by the European Medicines Agency. The agency issued a positive opinion on Incyte's Opzelura ...

Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic ...

A study finds that a team-based online care model results in equivalent improvements in atopic dermatitis severity and ...

BROADEN2 enrollment completed nearly six months ahead of anticipated timelinesKT-621 Phase 3 trials in AD planned to initiate by mid-2027KT-621 ...

Kymera Therapeutics Inc. KYMR shares are trading higher by more than 21% on Thursday as the company has completed enrollment ...

Phase 1b clinical trial of SYX-5219 in adults with moderate to severe atopic dermatitis completes enrollment ahead of scheduleRapid progress in ...

Whole goat milk-based formula is associated with reduced risk for atopic dermatitis in infants, a randomized clinical trial ...

New research reveals prolonged glucocorticosteroid use increases adverse events in atopic dermatitis. Learn more about safer ...

Some people develop atopic dermatitis in places that can affect sexual intimacy. Atopic dermatitis may also affect body image. Treatment and communicating with a partner may help. Atopic dermatitis ...

Red, itchy, and scaly skin from atopic dermatitis and eczema can be uncomfortable, confusing, and all too familiar. These chronic (meaning they can last a long time) inflammatory conditions can appear ...

The pharmaceutical company gains a prospective blockbuster with the deal, but is it worth $10.9 billion?